Welcome to Library
Annual Reports
RMRIMS News Bulletine
Publication of Dr. Shyam Narayan
 

15.

Shivam P, Jamal F, Kumari S, Bimal S, Narayan S, Das VN, Pandey K, Gupta AK, Singh D, Verma N, Das P and Singh SK. Leishmania donovani: Influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis. Hum Immunol. 2013; 74(12): 1575-1578. doi: 10.1016/j.humimm.2013.08.007. (Epub 2013 Aug 20).

14.

Thakur AK, Bimal S, Singh SK, Gupta AK, Das VN, Das P and Narayan S. Degree of anemia correlates with increased utilization of heme by Leishmania donovani parasites in visceral leishmaniasis. Exp Parasitol. 2013; 135(3): 595-598. doi: 10.1016/j.exppara.2013.09.008.

13.

Gupta AK, Narayan S, Singh SK, Thakur AK and Das P. Agar barrier method for removal of yeast and other fungal contamination from Leishmania promastigotes culture. Pathog Glob Health. 2012; 106(7): 418-420. (Doi: 10.1179/2047773212Y.0000000034).

12.

Gupta AK, Narayan S, Verma N, Thakur AK, Das P. Viscerotropic potential of parasites isolated from post-kala-azar dermal leishmaniasis cases: An experimental evidence. J Vector Borne Dis. 2012; 49(4): 266-267.

11.

Bimal S, Sinha S, Singh SK, Narayan S, Kumar V, Verma N, Ranjan A, Sinha PK, Das VN, Pandey K, Kar SK and Das P. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection. Exp Parasitol. 2012; 131(3): 274-282. (Epub 2012 May 10).

10.

Singh SK, Bimal S, Narayan S, Jee C, Bimal D, Das P and Bimal R. Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India. Exp Parasitol, 2011; 127(2): 552-558. (Epub 2010 Nov 9).

9.

Narayan S, Bimal S, Singh SK, Gupta AK, Singh VP, Sinha PK and Das P. Leishmania donovani vs Immunity: T-cells sensitized from Leishmaniaof one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis. Experimental Parasitology, 2009; 121: 69-75.


8.

Thakur CP, Thakur S, Narayan S and Sinha A. Comparison of treatment regimens of kala-azar based on culture and sensitivity of amastigotes to sodium antimony gluconate. Indian journal of Medical Research, 2008; 127: 573-580.


7.

Narayan S, Gupta AK, Singh Subhankar K, Lal CS, Singh VP, Sinha PK, Das P and Thakur CP. Clinical and Laboratory comparision of different brands of Amphotericin B used for the treatment of kala-azar. Journal of Communicable Diseases, 2008; 40(4): 273-276.


6.

Muniaraj M, Gupta AK, Narayan S, Singh D, Sinha PK, Das P. Long-term preservation of Leishmania donovani promastigotes on blood-agar slants, Ann Trop Med Parasitol. 2006; 100(2): 173-175.

5.

Muniaraj M, Gupta AK, Narayan S, Kumar S, Sinha PK, Kishore K and Das P. Removal of bacterial and yeast contamination from Leishmania promastigote cultures, by agar plating. Ann Trop Med Parasitol. 2005; 99(6): 617-621.

4.

Muniaraj M, Gupta AK, Narayan S, Singh D, Sinha PK, Kishore K, Das P and Bhattacharya SK. Preservation of Leishmania donovani promastigotes in blood agar slants. Journal of communicable Diseases, 2005; 37(3): 191-195.

3.

Thakur CP, Narayan S and Ranjan A.Epidemiological, Clinical & pharmacologocal study of antimony resistant visceral leishmaniasis in Bihar,India. Indian Journal of Medical Research, 2004; 120: 166-172.


2.

Thakur CP, Narayan S and Ranjan A. Kala-Azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: is this combination increasing?. J Acqir Immune Defic Syndrome, 2003; 32(5): 572-573.


1.

Gupta AK, Narayan S and Saran R.  Blood based autoclavable medium for in-vitro cultivation of Leishmania donovani promastigotes. Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, 1995; 16(3&4):144-145.